These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23625033)

  • 1. Thermodynamic computational approach to capture molecular recognition in the binding of different inhibitors to the DNA gyrase B subunit from Escherichia coli.
    Saíz-Urra L; Pérez MÁ; Froeyen M
    J Mol Model; 2013 Aug; 19(8):3187-200. PubMed ID: 23625033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of new DNA gyrase inhibitors based on bioactive compounds from streptomyces: structure-based virtual screening and molecular dynamics simulations approaches.
    Kalhor H; Sadeghi S; Marashiyan M; Kalhor R; Aghaei Gharehbolagh S; Akbari Eidgahi MR; Rahimi H
    J Biomol Struct Dyn; 2020 Feb; 38(3):791-806. PubMed ID: 30916622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the conformational changes of the ATP binding site of gyrase B from Escherichia coli complexed with different established inhibitors by using molecular dynamics simulation: protein-ligand interactions in the light of the alanine scanning and free energy decomposition methods.
    Saíz-Urra L; Cabrera MA; Froeyen M
    J Mol Graph Model; 2011 Feb; 29(5):726-39. PubMed ID: 21216167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico study directed towards identification of the key structural features of GyrB inhibitors targeting MTB DNA gyrase: HQSAR, CoMSIA and molecular dynamics simulations.
    Kamsri P; Punkvang A; Hannongbua S; Suttisintong K; Kittakoop P; Spencer J; Mulholland AJ; Pungpo P
    SAR QSAR Environ Res; 2019 Nov; 30(11):775-800. PubMed ID: 31607177
    [No Abstract]   [Full Text] [Related]  

  • 5. Computational Approaches to Develop Isoquinoline Based Antibiotics through DNA Gyrase Inhibition Mechanisms Unveiled through Antibacterial Evaluation and Molecular Docking.
    Alagumuthu M; Muralidharan VP; Andrew M; Ahmed MH; Iyer SK; Arumugam S
    Mol Inform; 2018 Dec; 37(12):e1800048. PubMed ID: 30051592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors.
    Azam MA; Thathan J
    SAR QSAR Environ Res; 2017 Apr; 28(4):275-296. PubMed ID: 28399673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining molecular docking and QSAR studies for modelling the antigyrase activity of cyclothialidine derivatives.
    Saíz-Urra L; Cabrera Pérez MÁ; Helguera AM; Froeyen M
    Eur J Med Chem; 2011 Jul; 46(7):2736-47. PubMed ID: 21530019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB.
    Mesleh MF; Cross JB; Zhang J; Kahmann J; Andersen OA; Barker J; Cheng RK; Felicetti B; Wood M; Hadfield AT; Scheich C; Moy TI; Yang Q; Shotwell J; Nguyen K; Lippa B; Dolle R; Ryan MD
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1314-8. PubMed ID: 26786695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linker-switch approach towards new ATP binding site inhibitors of DNA gyrase B.
    Jukič M; Ilaš J; Brvar M; Kikelj D; Cesar J; Anderluh M
    Eur J Med Chem; 2017 Jan; 125():500-514. PubMed ID: 27689732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
    Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the interaction of N-(benzothiazol-2-yl)pyrrolamide DNA gyrase inhibitors with the GyrB ATP-binding site lipophilic floor: A medicinal chemistry and QTAIM study.
    Zidar N; Emanuel Cotman A; Sinnige W; Benek O; Barančokova M; Zega A; Peterlin Mašič L; Tomašič T; Ilaš J; Henderson SR; Mundy JEA; Maxwell A; Stevenson CEM; Lawson DM; Jan Sterk G; Tosso R; Gutierrez L; Enriz RD; Kikelj D
    Bioorg Med Chem; 2024 Jul; 109():117798. PubMed ID: 38906068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site.
    Tomašič T; Katsamakas S; Hodnik Ž; Ilaš J; Brvar M; Solmajer T; Montalvão S; Tammela P; Banjanac M; Ergović G; Anderluh M; Peterlin Mašič L; Kikelj D
    J Med Chem; 2015 Jul; 58(14):5501-21. PubMed ID: 26098163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors.
    Durcik M; Tammela P; Barančoková M; Tomašič T; Ilaš J; Kikelj D; Zidar N
    ChemMedChem; 2018 Jan; 13(2):186-198. PubMed ID: 29206345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel oxoindolin derivatives as atypical dual inhibitors for DNA Gyrase and FabH.
    Yang YS; Su MM; Xu JF; Liu QX; Bai LF; Hu XW; Zhu HL
    Bioorg Chem; 2019 Dec; 93():103309. PubMed ID: 31585266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site.
    Gradisar H; Pristovsek P; Plaper A; Jerala R
    J Med Chem; 2007 Jan; 50(2):264-71. PubMed ID: 17228868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening.
    Ostrov DA; Hernández Prada JA; Corsino PE; Finton KA; Le N; Rowe TC
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3688-98. PubMed ID: 17682095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of (quinolin-4-ylthio)carboxylic acids as new Escherichia coli DNA gyrase B inhibitors: machine learning studies, molecular docking, synthesis and biological testing.
    Metelytsia L; Hodyna D; Dobrodub I; Semenyuta I; Zavhorodnii M; Blagodatny V; Kovalishyn V; Brazhko O
    Comput Biol Chem; 2020 Apr; 85():107224. PubMed ID: 32018168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
    Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
    Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of quercetin binding site on DNA gyrase.
    Plaper A; Golob M; Hafner I; Oblak M; Solmajer T; Jerala R
    Biochem Biophys Res Commun; 2003 Jun; 306(2):530-6. PubMed ID: 12804597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Driving forces of gyrase recognition by the addiction toxin CcdB.
    Simic M; De Jonge N; Loris R; Vesnaver G; Lah J
    J Biol Chem; 2009 Jul; 284(30):20002-10. PubMed ID: 19465484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.